QBIO News and Press, Q BioMed Inc From 04/07/20

Q BioMed ( OTCQB:QBIO ) has entered into a financial transaction with Yorkville Advisors Global (YA). More news on: Q BioMed Inc., Read more ...

April 7, 2020 Palm Beach, FL – April 7, 2020  – Many companies searching for an effective therapy or vaccine for the present world health crisis are focusing on creating a vaccine from the immune system. Key to the race to develop a vaccine for the new coronavirus i...

NEW YORK , April 7, 2020 /PRNewswire/ --   Q BioMed Inc.  (OTCQB: QBIO ), a commercial stage biotech company, announced today the entering of a significant financial transaction with its lead investor, Yorkville Advisors Global ("YA"). Under the agreement, on clos...

NEW YORK , March 31, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company,  announced today the appointment of Geoff Fatzinger as the Global Head of Regulatory Affairs. Geoff will be responsible for providing strategic regulatory oversight t...

NEW YORK , March 30, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company,  announced today the appointment of Kristin Keller to the newly created position of Chief Commercial Officer. Kristin will be focused on driving the global commercializati...

NEW YORK , March 12, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company,  announced today the first patient has been dosed in a commercial setting with its U.S. FDA approved non-opioid drug Strontium89   (Strontium Chloride Sr-89 Injection,...

March 12, 2020 Palm Beach, FL – March 12, 2020  – Opioid drugs are and have been a God-send for many patients whose severe, excruciating pain had no other drug or device to allow them to escape from its throes… But we all know that the other side of that coin...

February 13, 2020 Palm Beach, FL – February 13, 2020  – Opioid drugs are and have been a God-send for many patients whose severe, excruciating pain had no other drug or device to allow them to escape from its throes… But we all know that the other side of tha...

NEW YORK , Feb. 13, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today the launch of its FDA approved non-opioid drug Strontium89 (Strontium Chloride Sr-89 Injection, USP), which has been shown in clinical studies to help relie...

NEW YORK , Feb. 4, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its research partner Mannin Research Inc. (Mannin) is developing new therapeutics to treat a variety of vascular diseases, including the new coronavirus w...